![](dot.gif) |
Uro-oncology:
![](point-bullet.gif) |
Genome wide study on the potential genetic risk factors for prostate and bladder cancer |
![](point-bullet.gif) |
Verification of new diagnostic tests for prostate cancer |
![](point-bullet.gif) |
Role of narrow-band imaging for the diagnosis of bladder cancer |
|
![](dot.gif) |
Urolithiasis
|
![](dot.gif) |
Optimization of the performance of bladder cancer
|
![](dot.gif) |
Voiding dysfunction:
![](point-bullet.gif) |
Comparison of the performance of various endoscopic treatment for benign |
![](point-bullet.gif) |
prostate hyperplasia |
![](point-bullet.gif) |
Drug treatment for nocturia |
![](point-bullet.gif) |
Management and pathology of ketamine induced bladder dysfunction |
|
![](dot.gif) |
Andrology:
![](point-bullet.gif) |
Late onset hypogonadism
|
|